Target intelligence / Profile preview

Ventral anterior homeobox 1 (VAX1)

Target
VAX1
Molecular classification
Transcription factor, Homeobox protein
01

Overview

Ventral anterior homeobox 1 (VAX1) is a homeodomain-containing transcription factor encoded by the VAX1 gene, part of the homeobox gene family highly conserved in vertebrates. VAX1 plays a crucial regulatory role in the development of the anterior ventral forebrain, midline brain structures, and visual system; it is also essential for craniofacial morphogenesis. Mutations or deficiency in VAX1 in both humans and animal models cause developmental abnormalities, including microphthalmia (small eyes), cleft lip/palate, corpus callosum agenesis, and visual system defects. Expression is primarily in the forebrain and in developmentally relevant regions such as the palate, optic stalk, and visual eye fields. Recent findings also suggest secreted VAX1 has a non-transcriptional role as an axon growth factor for retinal ganglion cells, binding to heparan sulfate proteoglycans to guide axonal growth, a unique mechanism among transcription factors. VAX1 shows no known direct pharmacological targeting or interacting drugs and is not currently a therapeutic drug target; its relevance is primarily in developmental biology and human genetics.

Other names
MCOPS11LOC108349709ventral anterior homeobox 1
02

Biological functions

Regulation of forebrain developmentOcular developmentCraniofacial morphogenesisRegulation of axon growthBrain midline structure development
03

Disease associations

Cleft lip and/or palateMicrophthalmia (syndromic 11; MCOPS11)Agenesis of midline brain structures (e.g. corpus callosum)Coloboma of the eyeOther congenital craniofacial malformations
04

Biomarkers

SNPs (e.g., rs6585429) in VAX1 are biomarkers for risk of non-syndromic cleft lip/palate and certain ocular/cranial defects

Beyond the preview

Go deeper on Ventral anterior homeobox 1 (VAX1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ventral anterior homeobox 1 (VAX1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call